Published in J Clin Oncol on January 01, 2006
Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol (2010) 2.04
Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy. Int J Clin Oncol (2008) 0.89
Which patients need an axillary clearance after sentinel node biopsy? Int J Breast Cancer (2011) 0.82
Sentinel node biopsy in early breast cancer at the Hospital Comarcal La Linea (Spain). Ecancermedicalscience (2013) 0.75
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med (2003) 11.93
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol (2013) 4.21
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol (2004) 3.87
Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg (2010) 3.61
NUMB controls p53 tumour suppressor activity. Nature (2008) 2.91
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment. Clin Cancer Res (2004) 2.46
Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol (2006) 2.36
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. J Clin Oncol (2012) 2.22
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. J Clin Oncol (2009) 1.85
Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer (2005) 1.73
Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg (2003) 1.63
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat (2010) 1.59
Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer (2004) 1.48
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol (2005) 1.47
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg (2005) 1.47
Axillary radiotherapy instead of axillary dissection: a randomized trial. Italian Oncological Senology Group. Ann Surg Oncol (2002) 1.46
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg (2005) 1.45
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin. Eur J Nucl Med Mol Imaging (2009) 1.45
Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer (2009) 1.28
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy. Breast Cancer Res Treat (2008) 1.24
Male breast cancer: a special therapeutic problem. Anything new? (Review). Int J Oncol (2004) 1.18
Invasive lobular breast cancer: subtypes and outcome. Breast Cancer Res Treat (2012) 1.11
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution. Cancer (2004) 1.11
Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer (2008) 1.06
Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome. Clin Breast Cancer (2012) 1.05
IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation. Breast (2006) 1.04
When sentinel lymph node is intramammary. Ann Surg Oncol (2007) 1.03
Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research. Breast J (2009) 1.02
Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann Surg Oncol (2007) 1.00
Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial. Cancer Prev Res (Phila) (2011) 0.99
The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat (2005) 0.96
Breast-conserving surgery in 201 very young patients (<35 years). Breast (2009) 0.95
Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. Int J Radiat Oncol Biol Phys (2008) 0.95
Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? Ann Surg Oncol (2009) 0.94
Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancer. Radiother Oncol (2005) 0.93
The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat (2005) 0.93
Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg (2002) 0.92
Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol (2005) 0.91
Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinoma. Arch Surg (2002) 0.90
Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging (2010) 0.89
Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat (2008) 0.89
Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases. Oncologist (2010) 0.88
Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users. Ann Surg Oncol (2002) 0.87
The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy. Breast Cancer Res Treat (2010) 0.87
BC-box protein domain-related mechanism for VHL protein degradation. Proc Natl Acad Sci U S A (2013) 0.86
Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer. Clin Cancer Res (2007) 0.86
Conservative treatment of breast cancer: its evolution. Breast Cancer Res Treat (2005) 0.86
Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat (2014) 0.85
Immediate breast reconstruction after mastectomy. Breast (2011) 0.85
Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat (2008) 0.85
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation. Breast Cancer Res Treat (2011) 0.85
Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome. Breast (2010) 0.84
E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev (2014) 0.84
Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat (2008) 0.83
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer. Breast Cancer Res Treat (2013) 0.83
Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates. Ann Surg Oncol (2012) 0.83
Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique. Ann Surg (2015) 0.83
Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer--authors' reply. Lancet Oncol (2013) 0.81
Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapy. Eur J Nucl Med Mol Imaging (2010) 0.80
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome. J Surg Oncol (2006) 0.80
Incidence, predictive factors, and prognosis for winged scapula in breast cancer patients after axillary dissection. Support Care Cancer (2014) 0.78
The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life. Breast Cancer Res Treat (2005) 0.78
Immediate breast reconstruction with expander in pregnant breast cancer patients. Breast (2013) 0.78
Local therapy for breast cancer in malignant lymphoma survivors. Breast (2011) 0.78
Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer (2006) 0.77
Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA. Breast Cancer Res Treat (2006) 0.77
Clinical utility of 99mTc-Sestamibi scintimammography in the management of equivocal breast lesions. Cancer Biother Radiopharm (2004) 0.76
Immediate breast reconstruction with prostheses after conservative treatment plus intraoperative radiotherapy. long term esthetic and oncological outcomes. Breast (2012) 0.76
Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution. Ann Surg Oncol (2011) 0.75
Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique. Ann Surg (2017) 0.75
Feasibility of lymphoscintigraphy for sentinel node identification after neo-adjuvant therapy. Ann Ital Chir (2017) 0.75
No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN). Eur J Cancer (2010) 0.75
Second malignancies following breast cancer treatment: a case-control study based on the Peridose methodology. Allegro project (task 5.4). Tumori (2012) 0.75
Report on a case of breast sarcoma metastatic to the axillary lymph nodes. Tumori (2006) 0.75
Erratum to: Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat (2015) 0.75
BRCA1/2 germline missense mutations: a systematic review. Eur J Cancer Prev (2017) 0.75